Regen BioPharma, Inc. (RGBPP)
Chart Events
Performance Outlook
| Previous Close | 0.0070 |
| Open | 0.0066 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.0050 - 0.0070 |
| 52 Week Range | 0.0040 - 11.6250 |
| Volume | |
| Avg. Volume | 639,609 |
| Market Cap | 261,299 |
| Beta (5Y Monthly) | 3.36 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0190 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- PR Newswire
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on March 3, 2023
Regen BioPharma, Inc. (OTC PINK: RGBPD) (OTC PINK: RGBAD) (a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies, RNA vaccines, RNA and DNA therapeutics and small molecule drugs) will be presenting at the Emerging Growth Conference on March 8, 2023 (https://emerginggrowth.com/conference/).
- GlobeNewswire
Presenting on the Emerging Growth Conference on March 8 Register Now
MIAMI, March 07, 2023 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 51st Emerging Growth Conference on March 8, 2023. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the conference here. Submit Questions for any of the presenting companies t
- PR Newswire
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on February 22, 2023
Regen BioPharma, Inc. (OTC PINK: RGBP) and (OTC PINK: RGBPP) (a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies, RNA vaccines, RNA and DNA therapeutics and small molecule drugs) will be presenting at the Emerging Growth Conference on February 22, 2023 (https://emerginggrowth.com/conference/).
